摘要:
The present invention provides methods of modulating the endometrium, including methods for inhibiting pregnancy and methods for treating gynecological bleeding disorders, such as dysfunctional uterine bleeding and endometrial bleeding. The methods generally involve administering to an individual in need thereof a vascular endothelial growth factor (VEGF) antagonist, e.g., a chimeric VEGF blocker, where the VEGF antagonist is administered during the post-menstrual repair phase. The invention further provides chimeric VEGF blockers formulated for use in inhibiting pregnancy and treating gynecological bleeding disorders, as well as kits and delivery systems comprising the formulations.
摘要:
The invention has disclosed a method for diagnosis of lens illnesses such as cataract. This method comprises the steps of detecting the HSF4 gene, transcript and/or protein in the subject and comparing it with the normal HSF4 gene, transcript and/or protein to determine whether there is any variation, wherein the variation indicates that the possibility of suffering lens illnesses, such as cataract, in the subject is higher than that in the normal population. The present invention also discloses the method and pharmaceutical composition for treating cataract and other lens illnesses.
摘要:
Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptides specific antibodies) are provided. Methods of using said reagents and diagnostic kits are also provided.
摘要:
The present invention addresses the treatment of age-related macular degeneration using regulation of pathogenic mechanisms similar to atherosclerosis. In further specific embodiments, compositions that increase reverse cholesterol transport are utilized as therapeutic targets for age-related macular degeneration. In a specific embodiment, the lipid content of the retinal pigment epithelium, and/or Bruch's membrane is reduced by delivering Apolipoprotein A1, particularly a mimetic peptide.
摘要:
The present invention relates to a method for the prophylaxis and/or treatment of stroke and other ischemic injury, wherein HDL is administered to a subject in need thereof, particularly by intravenous infusion.
摘要:
Disclosed herein is a composition and a method for the treatment of otitis media and paranasal sinusitis using human defensins, lysozyme and/or lactoferrin as a new class of non-antibiotic antimicrobials. From studies of otitis media and paranasal sinusitis, it was observed that certain innate immune modulators were important in the bodies response to the infection. Therefore, these innate immune modulators, lysozyme, lactoferrin, and defensins were tested for use as a non-antibiotic treatment for infection, particularly infections such as otitis media and sinusitis.
摘要:
Computational analysis was used to derive structural peptide formulas SALIVAR, SALIVAL, SALIVAN caracterising common repetitive fragments that reconstruct a large number of salivary proline rich proteins. Short repetitive sequences and variants of the mucin (MUKOSEPT) and collagen (PROCOL null) have been also derived. The purpose of the derived sequences is the modulation of cell and tissue growth, division and differentiation.
摘要:
This invention relates to a method of regulating apoptosis and/or proliferation in a cell, the method including the step of altering the expression and/or function in the cell of polypeptides based on Apoptosis Related Basic Protein.
摘要:
This invention comprises of construction of a recombinant CHO cell line that produces functional mannose binding lectin (MBL) and of special uses of MBL. Specially, use of MBL for development of a therapeutic agent for patients having systemic infection with viruses, bacteria, or fungus is described. More specifically, MBL as a trigger for complement activation and MBL so formulated to activate complement system for the purpose of treating patients with microbial infection.
摘要:
The present invention includes Myxine glutinosa cathelin-associated antimicrobial peptides and genes encoding these peptides. The invention also includes compositions an methods for producing these peptides as well as method of preventing and treating microbial infections using these peptides.